EmitBio Inc.

EmitBio Inc. is a pioneering biotechnology company dedicated to revolutionizing the treatment of respiratory diseases through its innovative light-based technology. Headquartered in Durham, North Carolina, at 4222 Emperor Blvd., Suite 470, EmitBio is committed to improving patient outcomes by harnessing the power of precisely engineered light to stimulate physiological signals and initiate healing at the cellular level.

EmitBio's proprietary technology platform is at the forefront of medical innovation, with a growing portfolio of products in the discovery, pre-clinical, and clinical stages of development. While initially focused on providing an at-home treatment for COVID-19, EmitBio is expanding its reach to develop a comprehensive suite of products designed to redefine the standard of care for various respiratory conditions. EmitBio Inc. is poised to make a significant impact on the healthcare landscape.

Driven by a commitment to scientific excellence and patient well-being, EmitBio continues to push the boundaries of biotechnology research. With its cutting-edge technology and dedicated team, EmitBio Inc. is dedicated to enhancing the quality of life for individuals affected by respiratory ailments. We invite the management of EmitBio to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.